| Erika Prescott, OTR/L | |
|
5181 Charlestown Crossing Way, New Albany, IN 47150-9473 | |
| (502) 345-7168 | |
| Not Available |
| Full Name | Erika Prescott |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5181 Charlestown Crossing Way, New Albany, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003461898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 31006956A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erika Prescott, OTR/L 5181 Charlestown Crossing Way, New Albany, IN 47150-9473 Ph: (502) 345-7168 | Erika Prescott, OTR/L 5181 Charlestown Crossing Way, New Albany, IN 47150-9473 Ph: (502) 345-7168 |
News Archive
In a paper that will be published on Thursday, April 29, 2004 in the New England Journal of Medicine, a team of scientists from Stanford University and Applied Biosystems, an Applera Corporation business, describe the identification of six genes associated with survival in diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin's lymphoma.
In the past 30 years the number of children living in the U.S. who are obese has more than doubled and the number of adolescents has tripled. In response, Loyola University Health System has created a Pediatric Weight Management Program designed to help families and communities in the fight against this epidemic.
BioLineRx, a biopharmaceutical development company, announced today the commencement of the PRESERVATION I clinical trial, a CE Mark registration trial of BCM (BL-1040), a novel medical device intended for the prevention of cardiac remodeling following an acute myocardial infarction (AMI).
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Docosahexaenoic acid (DHA), an omega-3 fatty acid, may protect against the accumulation of a protein believed to be linked to Alzheimer's disease, according to the results of a new study published in the March 30, 2005 issue of The Journal of Neuroscience. The study used Martek DHA, which is produced from microalgae.
› Verified 9 days ago
Mrs. Amy Marie Braun, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4915 Charlestown Rd, New Albany, IN 47150 Phone: 812-945-5221 | |
Ms. Robin Bryant, MS. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4212 Charlestown Rd Ste 3, New Albany, IN 47150 Phone: 812-949-3272 Fax: 812-949-3271 | |
Mrs. Kristin Marie Reed, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2525 Charlestown Rd, New Albany, IN 47150 Phone: 812-945-4063 | |
Tanner Scanlon, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4915 Charlestown Rd, New Albany, IN 47150 Phone: 812-945-5221 | |
Mr. John Michael Gay Jr., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4915 Charlestown Rd, New Albany, IN 47150 Phone: 812-945-5221 | |
Mrs. Christine Marie Roberts, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3625 Saint Joseph Rd, New Albany, IN 47150 Phone: 812-948-0670 |